Literature DB >> 8319992

Hypercholesterolemia promotes endothelial dysfunction in vitamin E- and selenium-deficient rats.

L Raij1, J Nagy, K Coffee, E G DeMaster.   

Abstract

Abnormal regulation of local vascular tone occurs early in human and experimental atherosclerosis. Impaired endothelium-dependent vascular relaxations mediated by endothelium-derived relaxing factor are an important contributor to these abnormalities. Endothelium-derived relaxing factor is nitric oxide released as such or attached to a carrier molecule. Oxidized lipoproteins impede endothelium-derived relaxing factor-mediated responses in vitro. We designed in vivo experiments to determine whether hypercholesterolemia with and without deficiency of two endogenous lipid antioxidants, vitamin E and selenium, would result in endothelial dysfunction. Vitamin E and selenium deficiencies were induced in a group of hypertension-prone Dahl salt-sensitive rats fed a diet high in cholesterol (4%) but low in NaCl (0.5%) for 18 weeks. Two other groups of Dahl salt-sensitive rats received diets sufficient in vitamin E and selenium but containing either high or normal cholesterol levels (control group). Serum cholesterol levels increased approximately 10-fold in the two groups of rats fed high-cholesterol diets. Systolic blood pressure was 143 +/- 3 mm Hg in high-cholesterol/vitamin E- and selenium-sufficient rats and 142 +/- 5 mm Hg in high-cholesterol/vitamin E- and selenium-deficient rats (P = NS). Mild intimal thickening and occasional mononuclear cell infiltration were observed in both of these groups. Serum vitamin E levels were decreased, whereas serum thiobarbituric acid-reactive substances and exhaled pentane (two indicators of endogenous lipid oxidation) were significantly increased in high-cholesterol/vitamin E- and selenium-deficient rats compared with high-cholesterol/vitamin E- and selenium-sufficient rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319992     DOI: 10.1161/01.hyp.22.1.56

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  LDL size and susceptibility to oxidation in experimental nephrosis.

Authors:  R Posadas-Sánchez; C Posadas-Romero; J Zamora-González; A Hernández-Ono; G Baños-Marhaber; O N Campos; J Pedraza-Chaverrí
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

2.  Adverse systemic arterial function in patients with selenium deficiency.

Authors:  Y-H Chan; C-W Siu; K-H Yiu; H-T Chan; S-W Li; S Tam; B M Cheung; C-P Lau; T H Lam; H-F Tse
Journal:  J Nutr Health Aging       Date:  2012-01       Impact factor: 4.075

3.  Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation.

Authors:  J F Keaney; Y Guo; D Cunningham; G T Shwaery; A Xu; J A Vita
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.

Authors:  J F Keaney; A Xu; D Cunningham; T Jackson; B Frei; J A Vita
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

5.  Alpha-tocopherol pretreatment improves endothelium-dependent vasodilation in aortic strips of young and aging rats exposed to oxidative stress.

Authors:  C Guarnieri; E Giordano; C Muscari; L Grossi; C M Caldarera
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

6.  Reduced Dietary Selenium Impairs Vascular Function by Increasing Oxidative Stress in Sprague-Dawley Rat Aortas.

Authors:  Ana Stupin; Anita Cosic; Sanja Novak; Monika Vesel; Ivana Jukic; Brigita Popovic; Krunoslav Karalic; Zdenko Loncaric; Ines Drenjancevic
Journal:  Int J Environ Res Public Health       Date:  2017-06-02       Impact factor: 3.390

7.  Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study.

Authors:  Luca Pecoraro; Thomas Zoller; Richard L Atkinson; Fulvio Nisi; Franco Antoniazzi; Paolo Cavarzere; Giorgio Piacentini; Angelo Pietrobelli
Journal:  Nutr Diabetes       Date:  2022-01-10       Impact factor: 5.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.